Error: Could not add to watchlist. X

BB Adamant Global Generika

+ Watchlist
ADAGGRI:SW
1,375.15
CHF
17.37
1.25%
As of 12:44:00 ET on 02/04/2016.
Fund Type
Open-End Fund
52Wk Range
1,375.15 - 1,767.46
1 Yr Return
-10.97%
YTD Return
-10.60%
Previous Close
1,392.52
52Wk Range
1,375.15 - 1,767.46
1 Yr Return
-8.77%
YTD Return
-10.60%
Fund Type
Open-End Fund
Objective
Foreign Blend
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 02/04/2016)
1,375.15
Total Assets (m CHF) (on 02/04/2016)
161.400
Inception Date
07/16/2010
Last Dividend (on 12/07/2015)
-
Dividend Indicated Gross Yield
-
Fund Managers
OLIVER KUBLI
Front Load Fee
1.20%
Back Load Fee
1.00%
Redemption Fee
1.00%
12b-1 Fee
-
Current Mgmt Fee
1.20%
Expense Ratio
1.22%
Top Fund Holdings
Name Position Value % of Fund
Allergan plc 30.00 k 9.12 m 5.16
Sawai Pharmaceutical Co Ltd 130.00 k 8.25 m 4.67
Lonza Group AG 50.00 k 7.26 m 4.11
Express Scripts Holding Co 80.00 k 6.81 m 3.86
Dr Reddy's Laboratories Ltd 100.00 k 6.39 m 3.62
Medy-Tox Inc 15.00 k 6.32 m 3.58
Coherus Biosciences Inc 230.00 k 6.31 m 3.57
Yuhan Corp 25.00 k 6.12 m 3.46
Endo International PLC 100.00 k 5.91 m 3.35
Teva Pharmaceutical Industries 100.00 k 5.83 m 3.30
Profile
BB Adamant Global Generika Fund is an open-ended investment company incorporated in Switzerland. The Fund's aim is to generate long-term capital growth through active management by investing in companies within the generic sector. The Fund's portfolio will be concentarted to around 30 to 50 stocks which fully meet Adamant's strict selection criteria.
ADDRESS
Balfidor Fondsleitung AG
Peter-Merian Strasse 47
CH 4002 Basel
Switzerland
PHONE
+41 800 850 050